CVS HEALTH CORP (CVS) Fundamental Analysis & Valuation

NYSE:CVS • US1266501006

80.57 USD
+0.08 (+0.1%)
At close: Mar 4, 2026
80.1513 USD
-0.42 (-0.52%)
After Hours: 3/4/2026, 7:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

CVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CVS have multiple concerns. CVS is not valued too expensively and it also shows a decent growth rate. CVS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. CVS Profitability Analysis

1.1 Basic Checks

  • In the past year CVS was profitable.
  • In the past year CVS had a positive cash flow from operations.
  • CVS had positive earnings in each of the past 5 years.
  • CVS had a positive operating cash flow in each of the past 5 years.
CVS Yearly Net Income VS EBIT VS OCF VS FCFCVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • CVS has a Return On Assets of 0.70%. This is comparable to the rest of the industry: CVS outperforms 51.49% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.35%, CVS is in line with its industry, outperforming 56.44% of the companies in the same industry.
  • The Return On Invested Capital of CVS (4.90%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CVS is below the industry average of 9.13%.
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROIC 4.9%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
CVS Yearly ROA, ROE, ROICCVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • CVS has a Profit Margin of 0.44%. This is comparable to the rest of the industry: CVS outperforms 50.49% of its industry peers.
  • In the last couple of years the Profit Margin of CVS has declined.
  • CVS has a Operating Margin (2.58%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CVS has declined.
  • With a Gross Margin value of 13.77%, CVS is not doing good in the industry: 66.34% of the companies in the same industry are doing better.
  • CVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
CVS Yearly Profit, Operating, Gross MarginsCVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CVS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CVS is destroying value.
  • The number of shares outstanding for CVS has been increased compared to 1 year ago.
  • CVS has less shares outstanding than it did 5 years ago.
  • CVS has a better debt/assets ratio than last year.
CVS Yearly Shares OutstandingCVS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CVS Yearly Total Debt VS Total AssetsCVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B 250B

2.2 Solvency

  • CVS has an Altman-Z score of 2.34. This is not the best score and indicates that CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CVS (2.34) is comparable to the rest of the industry.
  • The Debt to FCF ratio of CVS is 8.27, which is on the high side as it means it would take CVS, 8.27 years of fcf income to pay off all of its debts.
  • CVS's Debt to FCF ratio of 8.27 is in line compared to the rest of the industry. CVS outperforms 49.51% of its industry peers.
  • CVS has a Debt/Equity ratio of 0.80. This is a neutral value indicating CVS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CVS (0.80) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Altman-Z 2.34
ROIC/WACC0.65
WACC7.53%
CVS Yearly LT Debt VS Equity VS FCFCVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • CVS has a Current Ratio of 0.84. This is a bad value and indicates that CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CVS (0.84) is worse than 80.20% of its industry peers.
  • A Quick Ratio of 0.63 indicates that CVS may have some problems paying its short term obligations.
  • CVS has a worse Quick ratio (0.63) than 81.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.63
CVS Yearly Current Assets VS Current LiabilitesCVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CVS Growth Analysis

3.1 Past

  • CVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.54%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -2.11% on average over the past years.
  • CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.85%.
  • CVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.39% yearly.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%

3.2 Future

  • CVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.08% yearly.
  • CVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.27% yearly.
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue Next Year1.49%
Revenue Next 2Y3.12%
Revenue Next 3Y3.88%
Revenue Next 5Y4.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVS Yearly Revenue VS EstimatesCVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
CVS Yearly EPS VS EstimatesCVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

6

4. CVS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.94, which indicates a very decent valuation of CVS.
  • Based on the Price/Earnings ratio, CVS is valued cheaper than 87.13% of the companies in the same industry.
  • CVS is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 11.13, the valuation of CVS can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CVS is valued cheaply inside the industry as 87.13% of the companies are valued more expensively.
  • CVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.94
Fwd PE 11.13
CVS Price Earnings VS Forward Price EarningsCVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, CVS is valued a bit cheaper than 78.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.1
EV/EBITDA N/A
CVS Per share dataCVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • CVS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.64
PEG (5Y)N/A
EPS Next 2Y10.96%
EPS Next 3Y11.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. CVS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.41%, CVS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, CVS pays a better dividend. On top of this CVS pays more dividend than 97.03% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

  • The dividend of CVS has a limited annual growth rate of 5.96%.
  • CVS has paid a dividend for at least 10 years, which is a reliable track record.
  • CVS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.96%
Div Incr Years3
Div Non Decr Years28
CVS Yearly Dividends per shareCVS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • CVS pays out 192.14% of its income as dividend. This is not a sustainable payout ratio.
  • CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP192.14%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
CVS Yearly Income VS Free CF VS DividendCVS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
CVS Dividend Payout.CVS Dividend Payout, showing the Payout Ratio.CVS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CVS Fundamentals: All Metrics, Ratios and Statistics

CVS HEALTH CORP

NYSE:CVS (3/4/2026, 7:00:00 PM)

After market: 80.1513 -0.42 (-0.52%)

80.57

+0.08 (+0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners89.6%
Inst Owner Change3.35%
Ins Owners0.99%
Ins Owner Change-0.47%
Market Cap102.28B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts80
Price Target95.74 (18.83%)
Short Float %1.32%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend2.68
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr Years3
Div Non Decr Years28
Ex-Date01-22
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)-0.12%
PT rev (3m)3.53%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-5.01%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.03%
Revenue NQ rev (1m)-1.61%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-2.09%
Valuation
Industry RankSector Rank
PE 11.94
Fwd PE 11.13
P/S 0.25
P/FCF 13.1
P/OCF 9.61
P/B 1.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)6.75
EY8.38%
EPS(NY)7.24
Fwd EY8.99%
FCF(TTM)6.15
FCFY7.63%
OCF(TTM)8.38
OCFY10.4%
SpS316.73
BVpS59.25
TBVpS-28.18
PEG (NY)1.64
PEG (5Y)N/A
Graham Number94.86
Profitability
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROCE 6.3%
ROIC 4.9%
ROICexc 5.23%
ROICexgc 18.66%
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
FCFM 1.94%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.7%
Interest Coverage -3.47
Cash Conversion N/A
Profit Quality 441.57%
Current Ratio 0.84
Quick Ratio 0.63
Altman-Z 2.34
F-Score6
WACC7.53%
ROIC/WACC0.65
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.49%
Revenue Next 2Y3.12%
Revenue Next 3Y3.88%
Revenue Next 5Y4.27%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year24.82%
EBIT Next 3Y15.26%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%

CVS HEALTH CORP / CVS FAQ

What is the fundamental rating for CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to CVS.


What is the valuation status of CVS HEALTH CORP (CVS) stock?

ChartMill assigns a valuation rating of 6 / 10 to CVS HEALTH CORP (CVS). This can be considered as Fairly Valued.


What is the profitability of CVS stock?

CVS HEALTH CORP (CVS) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for CVS stock?

The Earnings per Share (EPS) of CVS HEALTH CORP (CVS) is expected to grow by 7.28% in the next year.


Can you provide the dividend sustainability for CVS stock?

The dividend rating of CVS HEALTH CORP (CVS) is 7 / 10 and the dividend payout ratio is 192.14%.